All In Biotech

Free tool

FAERS Monitor: Betimol

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020439 or its brand name (Betimol, Timolol). Reports on generic versions are filed under their own applications.

Reports

12,185

Serious

5,726

47% of reports

Hospitalization

2,394

Death reported

584

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • treatment failure3,052
  • drug ineffective817
  • fatigue493
  • hypersensitivity461
  • off label use418
  • dizziness415
  • diarrhoea409
  • dyspnoea368
  • nausea366
  • eye irritation362
  • fall332
  • headache317
  • eye pain312
  • vision blurred297
  • intraocular pressure increased286

Reports by year received

View as table
YearReports
20046
200515
200617
20079
200861
200994
2010116
2011164
2012164
2013325
2014433
2015568
2016670
2017674
2018850
2019903
20203,868
2021615
2022546
2023551
2024470
2025591
2026474

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,974 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment failureSignal3,05266.063.9188,814
intraocular pressure increasedSignal28639.535.210,458
eye irritationSignal36210.99.93,240
eye painSignal3129.68.62,386
hypersensitivitySignal4614.33.91,169
vision blurredSignal2973.73.3596
fall3321.71.5101
dizziness4151.41.356
dyspnoea3681.11.05
diarrhoea4091.11.03
fatigue4931.11.04
drug ineffective8171.11.04
headache3170.90.86
off label use4180.80.716
nausea3660.80.719

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.